Govt begins administering Moderna COVID-19 vaccine to children aged between 12 to 17 years

KATHMANDU, December 19: The government has begun administering Moderna COVID-19 vaccine to children aged between 12 to 17 years old from Sunday in 56 districts all across the country. The first jabs of the vaccine will be administered from December 19 to December 29, according to Dr Sangita Kaushal Mishra, spokesperson at the Ministry of Health and Population. The vaccination drive will be conducted in Taplejung, Sankhuwasabha, Okhaldubga, Kotang, Bhojpuri, Dhankuta, Terhathum, Panchthar, Illam and Udayapur in Province 1 and Siraha, Mahottari, Rautahat and Bara in Province 2. Likewise, the vaccine will be administered in Dolakha, Sindhupalchowk, Rasuwa, Dhading, Ramechhap and Makwanpur districts in Bagmati Province and Gorkha, Manang, Mustang, Myagdi, Lamjung, Tanahu, Nawalparasi (East), Syangja and Parbat in Gandaki Province. Also, in Lumbini Province, the vaccine will be administered in Rukum (East), Rolpa, Gulmi, Pyuthan, Argakanchi, Palpa, Nawalparasi (West), Kapilvastu and Bardiya districts. Similarly, the jabs will also be administered in Dolpa, Mugu, Humla, Jumla, Kalikot, Dailekh, Jajarkot and Salyan districts in Karnali Province and Bajura, Bhajang, Darchula, Baitadi, Doti, Achham and Kanchanpur districts in Sudurpaschim Province. The second doses of the vaccine will be inoculated to these children from January 16 to January 26 next year. Moreover, the government will be administering Pfizer COVID-19 vaccine to children in Kathmandu, Lalitpur, Bhaktapur, Kavrepalanchowk, Chitwan, Sindhuli, Dadeldhura and Surket districts from December 28 to January 6, according the health ministry.

पूर्ण विवरण

सम्बन्धित सामग्री

4 million doses of Moderna COVID-19 vaccine arriving in Nepal today

KATHMANDU, Jan 25: An additional four million doses of Moderna vaccine are arriving in Nepal from the United States. Of these, 1.6 million doses were delivered on Monday night and the remaining 2.34 million doses are being delivered to Nepal on Tuesday morning, according to the Logistics Management Section under the Department of Health Services(DHS).

Republica पौष २०७८

COVID-19 vaccination drive halted following syringe shortage

KATHMANDU, December 28: The government has halted COVID-19 vaccination drive for children aged between 12 to 17 years old due to shortage of syringe in the country. Earlier, the government had announced to inoculate COVID-19 vaccine to children of eight districts including Kathmandu, Bhaktapur and Lalitpur from today. The vaccination drive will soon begin once the syringe shortage is resolved, according to the Health Ministry. The government has already begun administering Moderna COVID-19 vaccine to children of 57 districts a week ago.

Ratopati English मंसिर २०७८

Over 35,000 students to be inoculated at school itself

As many as 35,000 students are to be inoculated with Moderna COVID-19 vaccine at schools in Tanahun.

The Himalayan Times मंसिर २०७८

Govt begins administering additional COVID-19 doses to elderly

KATHMANDU, December 16: The government has begun administering additional doses of COVID-19 vaccine to people older than 60 years old. The National COVID-19 Vaccination Advisory Committee has already recommended the government to administer the additional doses to elderly, according to Chairman of the committee, Dr Ramesh Kanta Adhikari. Those elederly who had received two shots of Verocell vaccine will receive an additional dose to boost their immunity. Likewise, the shots will also be administered to people with compromised immunity who have already received both shots of the vaccine, according to Sagar Dahal, chief of the Family Welfare Division. “The government has already begun administering the additional doses of COVID-19 vaccines from some of the vaccination centers in the Kathmandu Valley,” Dahal added. Similarly, the government has decided to inoculate the Moderna COVID-19 vaccine to children aged between 12 to 17 from December 19 to 29. The vaccination will be administered in schools in 57 districts across the country. Also, the government will soon begin administering booster doses of COVID-19 to the public once the 50 percent of total eligible population receives at least one shot of COVID-19 vaccine. So far, 47 percent of the total eligible population has been fully vaccinated against COVID-19 vaccine in the country. To maintain vaccine equality, the World Health Organization has prohibited the inoculation of booster doses before administering COVID-19 vaccine to at least 50 percent of the total eligible population. So far, Nepal has administered COVID-19 vaccine to as many as 20,995,536 people. Of them, 19,629,621 have received their first shots while 93,65,915 have received both shots, according to the Ministry of Health and Population.

Ratopati English कार्तिक २०७८

U.S. approves new booster of COVID-19 vaccines, "mix and match" dose

WASHINGTON, Oct. 20: The U.S. Food and Drug Administration (FDA) on Wednesday authorized COVID-19 booster doses of Moderna and Johnson & Johnson, and approved "mix and match" booster dose for currently available approved COVID-19 vaccines. The agency authorized the use of a single booster dose of the Moderna COVID-19 vaccine at least 6 months after completion of the primary shots to people 65 years of age and older, 18 through 64 years of age at high risk of severe COVID-19, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2. As for the Johnson & Johnson booster dose, the FDA authorized the use of a single booster dose at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older. A single booster dose of any of the available COVID-19 vaccines may be administered as a "mix and match" booster dose following completion of primary vaccination with a different available COVID-19 vaccine, according to the FDA. For instance, a person who got a Johnson & Johnson vaccine could receive one from Moderna or Pfizer-BioNTech as a booster. "The available data suggest waning immunity in some populations who are fully vaccinated," said Acting FDA Commissioner Janet Woodcock in a statement. "The availability of these authorized boosters is important for continued protection against COVID-19 disease." The decision came after an FDA advisory committee voted last week to recommend authorizing Moderna and Johnson & Johnson's COVID-19 booster doses. In September, the FDA authorized the first booster shots for the Pfizer-BioNTech COVID-19 vaccine, allowing a single booster dose of the Pfizer-BioNTech vaccine be administered at least 6 months after completion of the primary series to individuals 65 years of age and older, and 18 through 64 years of age with frequent institutional or occupational exposure to SARS-CoV-2. A recent study of the "mix and match" approach funded by the U.S. National Institutes of Health found no safety concerns using different vaccines as a booster. The study found that people who received the Johnson & Johnson vaccine produced stronger antibody levels after they got booster shots made by Moderna or Pfizer-BioNTech, compared to boosters from Johnson & Johnson.

Ratopati English आश्विन २०७८

WHO experts issue recommendations on Moderna COVID-19 vaccine

GENEVA: The World Health Organization (WHO) issued recommendations on Tuesday on the use of the Moderna COVID-19 vaccine and said it was working with the company to accelerate its approval of the shot for WHO emergency use listing. The WHO's Strategic Advisory Group of Experts on Immunization, known as SAGE, said that the vaccine should be given in two...

The Hinalayan Times पौष २०७७